Use Options For a Chance To Buy HZNP at a 53% Discount

Looking back to 125 days ago, Horizon Pharma plc (HZNP) priced a 15,350,000 share secondary stock offering at $28.25 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Tuesday, the stock is now 10.7% higher than the offering price..